Holen Sie sich die Stockscreener-App
12.43
2.81%
0.34
Handel nachbörslich:
12.43
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TNDM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$12.09
Offen:
$12.15
24-Stunden-Volumen:
1.85M
Relative Volume:
0.92
Marktkapitalisierung:
$839.89M
Einnahmen:
$796.00M
Nettoeinkommen (Verlust:
$-136.49M
KGV:
-5.9474
EPS:
-2.09
Netto-Cashflow:
$-64.24M
1W Leistung:
-1.04%
1M Leistung:
+14.88%
6M Leistung:
-35.16%
1J Leistung:
-70.89%
1-Tages-Spanne:
$12.07
$12.69
1-Wochen-Bereich:
$12.04
$13.18
52-Wochen-Spanne:
$9.98
$47.60
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Firmenname
Tandem Diabetes Care Inc
Sektor
Branche
Telefon
858-366-6900
Adresse
12400 HIGH BLUFF DRIVE, San Diego, CA
Vergleichen Sie TNDM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
12.43 | 816.91M | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
132.76 | 228.57B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
98.98 | 147.98B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
376.62 | 144.17B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.19 | 119.84B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
75.09 | 44.65B | 5.69B | 1.41B | 577.90M | 6.95 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-08 | Eingeleitet | Oppenheimer | Outperform |
| 2025-08-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-06-16 | Eingeleitet | Truist | Hold |
| 2025-04-10 | Eingeleitet | Mizuho | Neutral |
| 2025-03-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-03-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Eingeleitet | Bernstein | Outperform |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-10-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-22 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-04-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Hochstufung | Stifel | Hold → Buy |
| 2023-08-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-05-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-08-09 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Eingeleitet | Wells Fargo | Overweight |
| 2020-07-31 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-07-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-06-18 | Bestätigt | Raymond James | Outperform |
| 2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-06 | Eingeleitet | Raymond James | Outperform |
| 2020-02-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Eingeleitet | Guggenheim | Buy |
| 2019-10-04 | Hochstufung | UBS | Neutral → Buy |
| 2019-05-17 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-13 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-03-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-27 | Bestätigt | Lake Street | Buy |
| 2018-11-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-09-26 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten
TNDM Investor News: If You Have Suffered Losses in Tandem - GlobeNewswire
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Market Wrap: Whats the beta of Tandem Diabetes Care Inc stockJuly 2025 Setups & Technical Pattern Alert System - خودرو بانک
Tandem Diabetes (TNDM) Study Highlights Benefits of Control-IQ+ - GuruFocus
Tandem study- adults with type 2 diabetes benefit from automated insulin delivery, regardless of C-peptide levels - MarketScreener
0.8% HbA1c Reduction: Tandem's Automated Insulin System Works for All Type 2 Diabetes Patients, Study Shows - Stock Titan
Aug Patterns: Does Tandem Diabetes Care Inc. have strong fundamentalsPortfolio Value Report & Reliable Breakout Stock Forecasts - خودرو بانک
Acadian Asset Management LLC Takes Position in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Value Recap: Will Tandem Diabetes Care Inc stock benefit from M AEarnings Growth Summary & Risk Managed Trade Strategies - خودرو بانک
Earnings Recap: How is Tandem Diabetes Care Inc managing supply chain issues2025 Fundamental Recap & Safe Entry Point Identification - خودرو بانک
Diabetes warning issued over insulin pump error - MSN
Market Trends: Is Tandem Diabetes Care Incs growth already priced inJuly 2025 Pullbacks & Consistent Return Investment Signals - خودرو بانک
Fda Tandem Diabetes Care Issues Correction For Certain TSlim X2 Insulin Pumps - MarketScreener
Analysis Recap: Is Tandem Diabetes Care Inc part of any major indexBond Market & Consistent Profit Trading Strategies - خودرو بانک
Weekly Recap: Is Tandem Diabetes Care Inc forming bullish engulfing patternsJuly 2025 Institutional & Low Risk High Reward Trade Ideas - خودرو بانک
Top 3 Health Care Stocks That Are Preparing To Pump This Month - Sahm
Jim Cramer Calls Tandem Diabetes “Speculative Stock for Younger People” - Yahoo Finance
Tandem Diabetes Care (NASDAQ:TNDM) Now Covered by Oppenheimer - MarketBeat
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Average Rating of "Hold" by Brokerages - MarketBeat
Park West Asset Management LLC Sells 476,948 Shares of Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM - Business Wire
Edmond DE Rothschild Holding S.A. Makes New $4.84 Million Investment in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
What data driven models say about Tandem Diabetes Care Inc.’s future2025 Pullback Review & Free Growth Oriented Trading Recommendations - Newser
Insulin pump makers Tandem and Insulet post contrasting Q2 results - MSN
Short Interest in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Decreases By 34.1% - MarketBeat
Levi & Korsinsky Announces an Investigation on Behalf of Tandem Diabetes Care, Inc. (TNDM) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Elliott Wave Theory Predicts Pullback in Tandem Diabetes Care Inc.2025 Market Outlook & Technical Confirmation Trade Alerts - beatles.ru
Sessa Capital IM L.P. Acquires Shares of 4,466,307 Tandem Diabetes Care, Inc. $TNDM - MarketBeat
RSI Crosses Above 30 for Tandem Diabetes Care Inc. — Reversal in SightJuly 2025 Intraday Action & Risk Adjusted Buy and Sell Alerts - beatles.ru
TNDM's Analyst Ratings: Oppenheimer Lowers Price Target by 50% | - GuruFocus
Oppenheimer Adjusts Tandem Diabetes Care Price Target to $22 From $44, Maintains Outperform Rating - MarketScreener
Oppenheimer maintains Tandem Diabetes Care stock rating, lowers price target - Investing.com Canada
Jacobs Levy Equity Management Inc. Sells 189,444 Shares of Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Take Care Before Jumping Onto Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Even Though It's 27% Cheaper - 富途牛牛
First Light Asset Management LLC Sells 46,860 Shares of Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Using Ichimoku Cloud for Tandem Diabetes Care Inc. technicals2025 Volatility Report & Weekly High Return Opportunities - Newser
Should you wait for a breakout in Tandem Diabetes Care Inc.July 2025 Highlights & Consistent Growth Stock Picks - Newser
Is Tandem Diabetes Care Inc. a strong candidate for buy and holdInflation Watch & Free Reliable Trade Execution Plans - خودرو بانک
How does Tandem Diabetes Care Inc. perform in inflationary periodsDay Trade & Safe Swing Trade Setups - خودرو بانک
Long term hold vs stop loss in Tandem Diabetes Care Inc.Fed Meeting & Proven Capital Preservation Methods - Newser
Tandem Diabetes Care shares rise 2.42% premarket after mobile app approval. - AInvest
Analyzing recovery setups for Tandem Diabetes Care Inc. investorsQuarterly Performance Summary & Daily Volume Surge Signals - Newser
Backtesting results for Tandem Diabetes Care Inc. trading strategiesJuly 2025 Institutional & Weekly Top Performers Watchlists - Newser
What to expect from Tandem Diabetes Care Inc. in the next 30 daysWeekly Trade Recap & Fast Gain Swing Alerts - Newser
Technical signs of recovery in Tandem Diabetes Care Inc.July 2025 Action & Momentum Based Trading Ideas - Newser
Tick level data insight on Tandem Diabetes Care Inc. volatilityRisk Management & Stepwise Trade Signal Implementation - Newser
Trend analysis for Tandem Diabetes Care Inc. this weekSell Signal & Expert Approved Trade Ideas - Newser
Tandem Diabetes Care, Inc. Securities Lawsuit Investigation - Claim Depot
What is Tandem Diabetes Care Inc.’s valuation compared to sector2025 Stock Rankings & Precise Swing Trade Alerts - خودرو بانک
First-Ever Smartphone Insulin Bolus Control: Tandem's t:slim App Cleared in Canada for Diabetes Care - Stock Titan
Measuring Tandem Diabetes Care Inc.’s beta against major indicesIndex Update & Weekly Top Stock Performers List - Newser
Finanzdaten der Tandem Diabetes Care Inc-Aktie (TNDM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.40%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):